Data from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
Nicolien C. de Clercq(Amsterdam Neuroscience), Max Nieuwdorp(Amsterdam Institute for Addiction Research), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Willem M. de Vos(University of Helsinki), Henrik Bjørn Nielsen(Clinical Microbiomics (Denmark)), Andrei Prodan(AstraZeneca (Netherlands)), Mark Davids(Dana-Farber Cancer Institute), A.K. Groen, Robert Hemke(Amsterdam University Medical Centers), Helle Pedersen(University of Copenhagen), Tom van den Ende(Amsterdam Neuroscience)
Cited by 0
Related Papers
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria
|Applied and Environmental Microbiology|1998|1.4k
Enterotypes in the landscape of gut microbial community composition
|Nature Microbiology|2017|1.2k